FDA approves Ofev for the treatment of scleroderma
By NewsDesk @infectiousdiseasenews On Friday, the U.S. Food and Drug Administration approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease More...
Parkinson’s disease: FDA approves Nourianz as an add-on treatment
The U.S. Food and Drug Administration today approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” More...
Xeljanz Class Action Lawsuit
What is Xeljanz? Xeljanz is a medication which is manufactured by Pfizer. It is approved for the treatment of Rheumatoid arthritis (RA), Psoriatic arthritis (PSA), Ulcerative colitis (US). These are tablets taken More...
HGH Human Growth Hormone Review Uses & Side Effects
The human body produces a wide array of hormones, during different stages of life, in order to promote the proper growth and well-being of the body and the health in general. One of these hormones is known as Human More...
Breast cancer: FDA okays direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
The U.S. Food and Drug Administration this week authorized the Personal Genome Service Genetic Health Risk (GHR) Report for BRCA1/BRCA2 (Selected Variants). It is the first direct-to-consumer (DTC) test to report More...
Dietary Supplements: The Face of a Self-Regulating Industry
The pressure to look great weighs heavily on many. From people who want to lose weight to improve their overall health to those who want to lose weight to fit their ideal beauty standards, the dietary supplement More...
Profounda receives FDA Orphan Drug Designation for miltefosine for treating Primary Amebic Meningoencephalitis (PAM)
Profounda, Inc. announced Friday that it has received, the US Food and Drug Administration’s (FDA) Orphan Drug Designation for the treatment of Primary Amebic Meningoencephalitis (PAM) with miltefosine. More...
FDA passes Mifeprex changes, reducing cost for abortions despite risk to women
The Food and Drug Association (FDA) changed the regimen for mifepristone (Mifeprex), significantly reducing the obstacles, burden, and cost to abortionists. The move includes approval of new labeling for the abortion More...
Bristol-Myers Squibb’s, Empliciti, receives approval for the treatment of multiple myeloma
Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications. Multiple More...
Opdivo receives FDA nod to treat advanced form of kidney cancer
The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy. Photo/Madhero88 More...
HIV treatment, Genvoya, gets FDA nod
The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment More...
ADF files brief to make New Hampshire funding of Planned Parenthood records public
Alliance Defending Freedom attorneys filed a brief with the New Hampshire Supreme Court Wednesday to release all documents related to the state’s funding of abortion facilities and its continuing failure to regulate More...
Prevalent Poison: The Shocking Stats Behind Nursing Home Drugging
When people send their loved ones to a nursing home, they expect that they will be taken care of. But, some new findings suggest that elderly patients are being abused in these facilities. Here are some ways to More...
How the Mark of the Beast arrived in the 21st Century
It’s always easy for Christians in 2015 to proudly proclaim how they’ll refuse the “Mark of the Beast” as described in the Bible. These Christians never account or analyze how desperate they More...
Blood clot prevention drug, Savaysa, gets FDA approval
The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation More...
Novo Nordisk’s Saxenda receives FDA approval for chronic weight management treatment
The U.S. Food and Drug Administration today approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The More...
FDA approves Obizur for treating hemophilia A bleeding episodes in adults
The U.S. Food and Drug Administration approved Obizur [Antihemophilic Factor (Recombinant), Porcine Sequence] for the treatment of bleeding episodes in adults with acquired hemophilia A (acquired Factor VIII [FVII] More...
Diabetes drug, Trulicity, receives FDA approval
The U.S. Food and Drug Administration today approved Trulicity (dulaglutide), a once-weekly subcutaneous injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type More...
Vacations and Health – The new winning formula for travelers abroad
Many people around the world who simply cannot afford to undergo a medical procedure at home, due to a complex medical procedure or a simple cosmetic one, have got an opportunity to go to a foreign country and have More...
Sleep drug, Belsomra, gets FDA nod
The U.S. Food and Drug Administration today approved Belsomra (suvorexant) tablets for use as needed to treat difficulty in falling and staying asleep (insomnia). Belsomra is an orexin receptor antagonist and is More...
